ARROWHEAD PHARMACEUTICALS, INC. (ARWR) › Shares OutstandingARROWHEAD PHARMACEUTICALS, INC. (ARWR) — Shares OutstandingAnnual figures by period end, from SEC filings.2010-09-30: 7.17M2011-09-30: 8.64M2012-09-30: 13.58M2013-09-30: 32.49M2014-09-30: 54.66M2015-09-30: 59.54M2016-09-30: 69.75M2017-09-30: 74.79M2018-09-30: 88.51M2019-09-30: 95.51M2020-09-30: 102.38M2021-09-30: 104.33M2022-09-30: 105.96M2023-09-30: 107.31M2024-09-30: 124.38M2025-09-30: 135.70M135.70M2010-09-30Shares Outstanding (shares)2025-09-30Period endedShares OutstandingChange YoYSource filing2025-09-30135.70M+9.1%2025-11-25Balance as of period end2024-09-30124.38M+15.9%2025-11-25Balance as of period end2023-09-30107.31M+1.3%2024-11-26Balance as of period end2022-09-30105.96M+1.6%2023-11-29Balance as of period end2021-09-30104.33M+1.9%2022-11-28Balance as of period end2020-09-30102.38M+7.2%2021-11-22Balance as of period end2019-09-3095.51M+7.9%2020-11-23Balance as of period end2018-09-3088.51M+18.3%2019-11-25Balance as of period end2017-09-3074.79M+7.2%2018-12-11Balance as of period end2016-09-3069.75M+17.1%2017-12-12Balance as of period end2015-09-3059.54M+8.9%2016-12-14Balance as of period end2014-09-3054.66M+68.2%2015-12-14Balance as of period end2013-09-3032.49M+139.3%2014-11-25Balance as of period end2012-09-3013.58M+57.1%2013-12-18Balance as of period end2011-09-308.64M+20.5%2012-12-28Balance as of period end2010-09-307.17M—2011-12-20Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)